Chen Yanhong, Cheng Wei, Xiao Boneng, Tang Jia, Kuang Ming, Xu Liaoyi, Xu Xiaosa, Liu Hongying
Laboratory Animal Center of Zhejiang University, Zhejiang, China.
Hangzhou Kang Ming Information Technology Co., Ltd, Zhejiang, China.
Sci Prog. 2025 Jul-Sep;108(3):368504251348147. doi: 10.1177/00368504251348147. Epub 2025 Sep 4.
ObjectiveIschemic stroke, resulting from the interruption of blood supply to the brain, leads to cerebral ischemia, hypoxia, and necrosis, and is a prevalent disease characterized by high incidence, mortality, and disability rates. This study investigates the protective effects of ischelium on cerebral ischemia-reperfusion injury in a rat model, along with the potential mechanisms of action.MethodsWe established a rat cerebral ischemia-reperfusion model and administered different doses of ischelium as intervention across treatment groups. Multiple techniques were used to evaluate brain tissue damage, oxidative stress markers, inflammatory cytokine levels, and apoptosis, while also examining the expression of key proteins in the Nrf2/HO-1 antioxidant pathway and the HMGB1/TLR4/RAGE/NF-κB pro-inflammatory pathway.ResultsThe results indicate that ischemia-induced injury causes severe brain tissue damage and activates both the Nrf2/HO-1 antioxidant pathway and the HMGB1/TLR4/RAGE/NF-κB pro-inflammatory pathway, subsequently leading to oxidative stress, inflammation, and apoptosis. Treatment with ischelium significantly alleviated the brain tissue damage induced by cerebral ischemia-reperfusion, promoted the Nrf2/HO-1 antioxidant pathway, and suppressed the HMGB1/TLR4/RAGE/NF-κB inflammatory pathway. Ischelium also reduced MDA levels and increased SOD, CAT, and GSH levels, while inhibiting the production of pro-inflammatory cytokines IL-6, IL-1β, TNF-α and apoptosis.ConclusionsThese findings suggest that ischelium confers neuroprotective effects against cerebral ischemia-reperfusion injury, likely by regulating oxidative stress and neuroinflammation. Further investigations into the exact molecular mechanisms and clinical translations of ischelium may lead to novel therapeutic approaches for ischemic stroke.
目的
缺血性中风是由于大脑血液供应中断导致脑缺血、缺氧和坏死,是一种发病率、死亡率和致残率都很高的常见疾病。本研究探讨了异嗪皮啶对大鼠脑缺血再灌注损伤的保护作用及其潜在作用机制。
方法
我们建立了大鼠脑缺血再灌注模型,并在各治疗组中给予不同剂量的异嗪皮啶作为干预措施。采用多种技术评估脑组织损伤、氧化应激标志物、炎性细胞因子水平和细胞凋亡情况,同时检测Nrf2/HO-1抗氧化途径和HMGB1/TLR4/RAGE/NF-κB促炎途径中关键蛋白的表达。
结果
结果表明,缺血诱导的损伤会导致严重的脑组织损伤,并激活Nrf2/HO-1抗氧化途径和HMGB1/TLR4/RAGE/NF-κB促炎途径,随后导致氧化应激、炎症和细胞凋亡。异嗪皮啶治疗显著减轻了脑缺血再灌注诱导的脑组织损伤,促进了Nrf2/HO-1抗氧化途径,抑制了HMGB1/TLR4/RAGE/NF-κB炎症途径。异嗪皮啶还降低了丙二醛水平,提高了超氧化物歧化酶、过氧化氢酶和谷胱甘肽水平,同时抑制了促炎细胞因子白细胞介素-6、白细胞介素-1β、肿瘤坏死因子-α的产生和细胞凋亡。
结论
这些发现表明,异嗪皮啶可能通过调节氧化应激和神经炎症对脑缺血再灌注损伤具有神经保护作用。对异嗪皮啶的确切分子机制和临床转化进行进一步研究,可能会为缺血性中风带来新的治疗方法。